Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NewAmsterdam Pharma N.V.

    NASDAQ: NAMSW · Real-Time Price · USD
    8.79
    -1.28 (-12.71%)
    At close: Jun 13, 2025, 3:11 PM
    9.41
    7.05%
    After-hours: Jun 13, 2025, 04:00 PM EDT

    NewAmsterdam Pharma Statistics

    Share Statistics

    NewAmsterdam Pharma has 223.92M shares outstanding. The number of shares has increased by 0.36% in one year.

    Shares Outstanding

    n/a
    		 223.92M

    Shares Change (YoY)

    n/a
    		 0.36%

    Shares Change (QoQ)

    n/a
    		 -8.04%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 119.54M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    PE Ratio

    n/a
    		 n/a

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 71.91

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.18

    P/FCF Ratio

    n/a
    		 n/a

    PEG Ratio

    n/a
    		 undefined
    Financial Ratio History

    Enterprise Valuation

    NewAmsterdam Pharma has an Enterprise Value (EV) of 577.36M.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.95, with a Debt / Equity ratio of undefined.

    Current Ratio

    n/a
    		 6.95

    Quick Ratio

    n/a
    		 6.95

    Debt / Equity

    n/a
    		 n/a

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 undefined

    Financial Efficiency

    Return on Equity is -0.61% and Return on Invested Capital is -57.46%.

    Return on Equity

    n/a
    		 -0.61%

    Return on Assets

    n/a
    		 -0.51%

    Return on Invested Capital

    n/a
    		 -57.46%

    Revenue Per Employee

    n/a
    		 $205,850.35

    Profits Per Employee

    n/a
    		 $-2,853,822.58

    Employee Count

    n/a
    		 62

    Asset Turnover

    n/a
    		 0.04

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 27K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0, so NewAmsterdam Pharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 12.02

    200-Day Moving Average

    n/a
    		 9.59

    Relative Strength Index (RSI)

    n/a
    		 35.07

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, NewAmsterdam Pharma had revenue of 12.76M and earned -176.94M in profits. Earnings per share was -2.15.

    Revenue

    n/a
    		 12.76M

    Gross Profit

    n/a
    		 12.76M

    Operating Income

    n/a
    		 -165.73M

    Net Income

    n/a
    		 -176.94M

    EBITDA

    n/a
    		 -176.86M

    EBIT

    n/a
    		 -165.73M

    Earnings Per Share (EPS)

    n/a
    		 -2.15
    Full Income Statement

    Balance Sheet

    The company has 340.45M in cash and 60K in debt, giving a net cash position of 340.39M.

    Cash & Cash Equivalents

    n/a
    		 340.45M

    Total Debt

    n/a
    		 60K

    Net Cash

    n/a
    		 340.39M

    Retained Earnings

    n/a
    		 -316.97M

    Total Assets

    n/a
    		 439.19M

    Working Capital

    n/a
    		 396.62M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -141.22M and capital expenditures -24K, giving a free cash flow of -141.24M.

    Operating Cash Flow

    n/a
    		 -141.22M

    Capital Expenditures

    n/a
    		 -24K

    Free Cash Flow

    n/a
    		 -141.24M

    FCF Per Share

    n/a
    		 -1.72
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1298.56% and -1386.36%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1298.56%

    Pretax Margin

    n/a
    		 -1255.57%

    Profit Margin

    n/a
    		 -1386.36%

    EBITDA Margin

    n/a
    		 -1385.76%

    EBIT Margin

    n/a
    		 -1298.56%

    FCF Margin

    n/a
    		 -1106.68%

    Dividends & Yields

    NAMSW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NAMSW.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 19.1

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist